Антираковая диета. Продукты, которые мы должны есть, чтобы защититься от опасного недуга - Давид Хаят

{56} Shanafelt T. D., Lee Y. K., Call T. G., Nowakowski G. S., Dingli D., Zent C. S., Kay N. E., «Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies», Leuk. Res., 2006, 30 (6), p. 707–712.

{57} Tsao A. S., Liu D., Martin J., Tang X. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao L., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., «Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions», Cancer Prev. Res. (Phila Pa), 2009, 2 (11), p. 931–941.

{58} Tsao A. S., Liu D., Martin J., Tang X. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao L., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., «Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions», op. cit.

{59} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{1} Vidal, Le Guide Vidal des compléments alimentaires disponible en librairie, Communiqué de Presse, 2010. Disponible sur: http://www. vidal.fr/presse/espace-grand-public/363-guide-complements-alimentaires (consulté le 15 mars 2010).

{2} AFSSA, Etude individuelle nationale des consommations alimentaires 2 (INCA 2) 2006–2007, 2009. Disponible sur: http://www.afssa.fr/ Documents/PASER-Ra-INCA2.pdf (consulté le 15 mars 2010).

{3} Ferrucci L. M., McCorkle R., Smith T., Stein K. D., Cartmel B., «Factors related to the use of dietary supplements by cancer survivors», J. Altern. Complement. Med., 2009, 15 (6), p. 673–680.

{4} Cassileth B. R., Heitzer M., Wesa K., «The public health impact of herbs and nutritional supplements», Pharm. Biol., 2009, 47 (8), p. 761–767.

{5} Kimura Y., Ito H., Ohnishi R., Hatano T., «Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity», Food Chem. Toxicol., 2009, 48 (1), p. 429–435.

{6} Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Meyskens F. L. Jr, Omenn G. S., Valanis B., Williams J. H. Jr., «The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements», J. Natl. Cancer Inst., 2004, 96 (23), p. 1743–1750.

{7} Virtamo J., Pietinen P., Huttunen J. K., Korhonen P., Malila N., Virtanen M. J., Albanes D., Taylor P. R., Albert P., ATBC Study Group, «Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up», JAMA, 2003, 290 (4), p. 476–485.

{8} Cook N. R., Le I. M., Manson J. E., Buring J. E., Hennekens C. H., «Effects of beta-carotene supplementation on cancer Incidence by baseline characteristics in the Physicians’ Health Study (United States)», Cancer Causes Control, 2000, 11 (7), p. 617–626.

{9} Lee I. M., Cook N. R., Manson J. E., Buring J. E., Hennekens C. H., «Beta-carotene supplementation and Incidence of cancer and cardiovascular disease: The Women’s Health Study», J. Natl. Cancer Inst., 1999, 91 (24), p. 2102–2106.

{10} De Klerk N. H., Musk A. W., Ambrosini G. L., Eccles J. L., Hansen J., Olsen N., Watts V. L., Lund H. G., Pang S. C., Beilby J., Hobbs M. S., «Western perth asbestos workers, Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene», Int. J. Cancer, 1998, 75 (3), p. 362–367.

{11} Hercberg S., Kesse-Guyot E., Druesne-Pecollo N., Touvier M., Favier A., Latino-Martel P., Briançon S., Galan P., «Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: A postintervention follow-up in the SU.VI.MAX Study», Int. J. Cancer, 2010, epub.

{12} Meyer F., Galan P., Douville P., Bairati I., Kegle P., Bertrais S., Estaquio C., Hercberg S., «Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial», Int. J. Cancer, 2005, 116 (2), p. 182–186.

{13} Hercberg S., Ezzedine K., Guinot C. et al., «Antioxidant supplementation increases the risk of skin cancers in women but not in men», J. Nutr., 2007, 137, p. 2098–2105.

{14} Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L. Jr, Valanis B., Williams J. H. Jr, Barnhart S., Cherniack M. G., Brodkin C. A., Hammar S., «Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial», J. Natl. Cancer Inst, 1996, 88 (21), p. 1550–1559.

{15} National Cancer Institute, Selenium and Vitamin E Cancer Prevention Trial (SELECT), 2008. Disponible sur: http://www.cancer.gov/ newscenter/pressreleases/SELECTQandA (consulté le 15 mars 2010).

{16} Nelson R. L., «Iron and colorectal cancer risk, human studies», Nutr. Rev., 2001, 59, p. 140–148.

{17} Duffield-Lillico A. J., Dalkin B. L., Reid M. E., Turnbull B. W., Slate E. H., Jacobs E. T., Marshall J. R., Clark L. C., «Nutritional Prevention of Cancer Study Group. Selenium supplementation, baseline plasma selenium status and Incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial», BJU Int. 2003, 91 (7), p. 608—6012.

{18} Clark L. C., Combs G. F. Jr, Turnbull B. W., Slate E. H., Chalker D. K., ChowJ., Davis L. S., Glover R. A., Graham G. F., Gross E. G., KrongradA., Lesher J. L. Jr, Park H. K., Sanders B. B. Jr, Smith C. L., Taylor J. R., «Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial», JAMA, 1996, 276 (24), p. 1957–1963.

{19} Ibid.

{20} World Cancer Resarch Fund, Food, Nutrition, Physical Activity and the Prevention of Cancer. A Global Perspective, op. cit.

{21} Ibid.

{22} Jenab M., Bueno-de-Mesquita H. B., Ferrari P., Van Duijnhoven F. J., Norat T., Pischon T., Jansen E. H., Slimani N., Byrnes G., Rinaldi S., Tjonneland A., Olsen A., Overvad K., Boutron-Ruault M. C., Clavel-Chapelon F., Morois S., Kaaks R., LinseisenJ., Boeing H., Bergmann M. M., Tichopoulou A., Misirli G., Trichopoulos D., Berrino F., Vineis P., Panico S., Palli D., Tumino R., Ros M. M., Van Gils C. H., Peeters P. H., Brustad M., Lund E., Tormo M. J., Ardanaz E., Rodriguez L., Sanchez M. J., Dorronsoro M., Gonzalez C. A., Hallmans G., Palmqvist R., Roddam A., Key T. J., Khaw K. T., Autier P., Hainaut P., Riboli E., «Association between prediagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: A nested case-control study», BMJ, 2010, 340, p. b5500.

{23} Ahn J., Albanes D., Peters U., Schatzkin A., Lim U., Freedman M., Chatterjee N., Andriole G. L., Leitzmann M. F., Hayes R. B., «Prostate, lung, colorectal, and ovarian trial project team. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial», Cancer Epidemiol Biomarkers Prev., 2007, 16 (12), p. 2623–2630.

{24} Ruhul Amin A. R. M., Kucuk O., Khuri F. R., Shin D. M., «Perspectives for cancer prevention with natural compounds», Journal of Clinical Oncology, 2009, 27 (18).

{25} Ibid.

{26} Hussain M., Banerjee M., Sarkar F. H. et al., «Soy isoflavones in the treatment of prostate cancer», Nutr. Cancer, 2006, 106, p. 1260–1268.

{27} Ibid.

{28} Pendleton J. M., Tan W. W., Anai S. et al., «Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy», BMC Cancer, 2008, 8 (132).

{29} Chao J. C., Chiang S. W., Wang C. C., Tsai Y. H., Wu M. S., «Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells», World J. Gastroenterol., 2006, 12 (28), p. 4478–4484.

{30} Luo Q., Li Z., Yan J., Zhu F., Xu R. J., Cai Y. Z., «Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer», J. Med. Food, 2009, 12 (4), p. 695–703.

{31} Mao F., Xiao B., Jiang Z., Zhao J., Huang X., Guo J., «Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest», J. Med. Oncol., 2010, epub.

{32} Miao Y., Xiao B., Jiang Z., Guo Y., Mao F., Zhao J., Huang X., GuoJ., «Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide», J. Med Oncol., 2009, epub.

{33} Li G., Sepkovic D. W., Bradlow H. L., Telang N. T., Wong G. Y., «Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism», Nutr. Cancer, 2009, 61 (3), p. 408–414.

{34} Chao J. C., Chiang S. W., Wang C. C., Tsai Y. H., Wu M. S., «Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells», op. cit.

{35} Ruhul Amin A. R. M., Kucuk O., Khuri F. R., Shin D. M., «Perspectives for cancer prevention with natural compounds», op. cit.

{1} Reeves G. K., Pirie K., Beral V., Green J., Spencer E., Bull D., «Cancer incidence and mortality in relation to body mass index in the million women studio: Cohort studio», BMJ, 2007, 335 (7630), p. 1134.

{2} Renehan A. G., Soerjomataram I., Tyson M., Egger M., Zwahlen M., Coebergh J. W., Buchan I., «Incident cancer burden attributable to excess body mass index in 30 European countries», Int. J. Cancer, 2010, 126 (3), p. 692–702.

{3} OMS, Obésité et surpoids, 2006. Disponible sur: http://www.who. int/media-centre/factsheets/fs311/fr/index.html (consulté le 8 février 2009).

{4} Ibid.

{5} Ibid.

{6} Stone R. J., Atlas of Skeletal Muscle, William C. Brown, 3e éd., 1999.

{7} InVs, Etude nationale nutrition santé 2006. Des consommations en fruits et légumes encourageantes chez l’adulte mais pas chez l’enfant. Vers une stabilisation du surpoids chez l’enfant mais encore un adulte sur six obèse, Communiqué de presse, 2007. Disponible sur: http://www.invs.sante. fr/presse/2007/communiques/nutrition_sante_121207/(consulté le 19 mars 2009).

{8} Ibid.

{9} Wu Y., «Overweight and obesity in China», BMJ, 2006, 333 (7564), p. 362–363.

{10} Bray G. A. «The epidemic of obesity and changes in food intake: The fluoride hypothesis», Physiol. Behav., 2004, 82 (1), p. 115–121.

{11} Burdette H. L., WIthaker R. C., «Neighborhood playgrounds, fast food restaurants, and crime: Relationships to overweight in low-income preschool children», Pev. Med., 2004, 38, p. S7—63.

{12} Ibid.

{13} Marshall S. J., Biddle S. J., Gorely T., Cameron N., Murdey I., «Relationships between media use, body fatness and physical activity in children and youth: A meta-analyses», Int. J. Obes. Relat. Metab. Disord., 2004, 28 (10), p. 1238–1246.

{14} Von Kries R., Toschke A. M., Wurmser H., Sauerwald T., Koletzko B., «Reduced risk for overweight and obesity in 5-and 6-y-old children by duration of sleep-a cross-sectional studio», Int. J. Obes. Relat. Metab. Disord., 2002, 26 (5), p. 710–716.

{15} Miles L., «Physical activity and health», Nutrition Bulletin, 2007, 32 (4), p. 314–363.

{16} Courneya K. S., Karvinen K. H., Campbell K. L., Pearcey R. G., Dundas G., Capstick V., Tonkin K. S., «Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors», Gynecol. Oncol., 2005, 97 (2), p. 422–430.

{17} Holmes M. D., Chen W. Y., Feskanich D., Kroenke C. H., Colditz G. A., «Physical activity and survival after breast cancer diagnosis», JAMA, 2005, 293 (20), p. 2479–2486.

{18} Pierce J. P., Stefanick M. L., Flatt S. W., Natarajan L., Sternfeld B., Madlensky L., Al-Delaimy W. K., Thomson C. A., Kealey S., Hajek R., Parker B. A., Newman V. A., Caan B., Rock C. L., «Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity», J. Clin. Oncol, 2007, 25 (17), p. 2345–2351.

{19} Knols R., Aaronson N. K., Uebelhart D., Fransen J., Aufdemkampe G., «Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials», J. Clin. Oncol., 2005, 23 (16), p. 3830–3842.

{20} Cramp F., Daniel J., «Exercice for the management of cancerrelated fatigue in adults», J. Clin. Oncol., chez Cochrane Database, 2008, epub.

{21} Irwin M. L., Smith A. W., McTiernan A., Ballard-Barbash R., Cronin K., Gilliland F. D., Baumgartner R. N., Baumgartner K. B., Bernstein L., «Influence of pre-and postdiagnosis physical activity on mortality in breast cancer survivors: The health, eating, activity, and lifestyle study», J. Clin. Oncol., 2008, 26 (24), p. 3958–3964.

{22} Holick C. N., Newcomb P. A., Trentham-Dietz A., Titus-Ernstoff L., Bersch A. J., Stampfer M. J., Baron J. A., Egan K. M., Willett W. C., «Physical activity and survival after diagnosis of invasive breast cancer», Cancer Epidemiol. Biomarkers Prev., 2008, 17 (2), p. 379–386.

{23} Pierce J. P., Stefanick M. L., Flatt S. W., Natarajan L., Sternfeld B., Madlensky L., Al-Delaimy W. K., Thomson C. A., Kealey S., Hajek R., Parker B. A., Newman V. A., Caan B., Rock C. L., «Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity», op. cit.